Primary Pulmonary Hypertension Legal Information from PPH Attorneys
Contact us if you suffer from Primary Pulmonary Hypertension
PPH Lawsuit
September 15, 1997, the prescription diet drug Fen Phen was withdrawn from the market due to the heart valve injuries affecting large quantities of individuals. Before the 1997 removal of Fen Phen from the shelves, individuals who had taken Pondimin or Redux pursued individual lawsuits, as well as class actions against the American Home Products Corporation after medical reports linked the drugs to dangerous forms of valvular heart disease.
A nationwide settlement began negotiations and American Home Products and the counsel for plaintiffs presented the Court a proposed Nationwide Class Action Settlement Agreement. Fen Phen cases are now in the second round of litigation after an initial $4 billion dollar settlement was agreed between American Home Products and lawyer for the class action settlement, it has now been indicated that it will be increased to $7.5 billion. While Fen Phen has negatively affected millions of people, there are only a small number of people who have taken legal action.
For those wishing legal representation for the serious health complications suffered as a result of taking Fen Phen, or for those wishing to opt-out of the class action and seek individual representation, we can help you. Our team of Fen Phen attorneys will provide the highest level of legal expertise to advise and seek proper compensation for anyone who has endured the side effects of the controversial diet drug. Contact us to discuss your case with one of our experienced attorneys.